Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03089866 · ClinicalTrials.gov registry record
Effect of Sedation on Cognitive Performance in the Elderly
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 20
- Enrollment target
NCT03089866 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants.
The verdict
NCT03089866 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The main goal of this study is to allow the anesthesiologist to make a more informed decision about the anesthetic requirement of a person prior to starting anesthesia. The preliminary data collected in this study will support a larger investigation aimed at gaining a better understanding of anesthetic susceptibility in general and in the elderly population which appears to be at greater risk for Postoperative Cognitive Dysfunction (POCD) POCD is a short-term decline in cognitive function (especially in memory and executive functions) that may last from a few days to a few weeks after surgery. In rare cases, this disorder may persist for several months after major surgery. POCD is distinct from emergence delirium. It occurs most commonly in older patients and those with pre-existing cognitive impairment. POCD is common in adult patients of all ages at hospital discharge after major non-cardiac surgery, but only the elderly (aged 60 years or older) are at significant risk for long-term cognitive problems. The body's inflammatory response to surgery likely plays an important role, at least in elderly patients. Investigators also postulate that a relative 'anesthetic overdose' may be a significant risk factor. Hence, being able to make a better judgment on the dose needed for an individual is extremely important.
Interventions
- DRUG Midazolam (0.02mg/kg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-03 |
| Est. Completion | 2020-09-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03089866
The ClinicalTrials.gov registry entry for NCT03089866 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Midazolam (0.02mg/kg) is the first listed.
NCT03089866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03089866 about?
NCT03089866 is a clinical study titled "Effect of Sedation on Cognitive Performance in the Elderly". The main goal of this study is to allow the anesthesiologist to make a more informed decision about the anesthetic requirement of a person prior to starting anesthesia. The preliminary data collected in this study will support a larger investigation aimed at gaining a better understanding of anesthe...
What is the current status of trial NCT03089866?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2015-03. Estimated completion is 2020-09-04.
What interventions are being tested in trial NCT03089866?
The interventions under investigation include: Midazolam (0.02mg/kg) (DRUG).
Who is sponsoring clinical trial NCT03089866?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.